Concepedia

Brian Czaya

BC

Statistics

Publications

7

Citations

624

H-Index

7

Active since

2016

Affiliations

University of Alabama at Birmingham(Current)

University of Miami

Duke University

Northwestern University

Stanford Medicine

Brian Czaya is an author at University of Alabama at Birmingham specializing in fibroblast growth factor 23 dysregulation, signal transduction, and life sciences.

ORCID

Publications per year

2016–2023

7

Publications

7

Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease

Saurav Singh, Alexander Grabner, Christopher Yanucil et al. · Kidney International · 2016 · 355 citations · Full text

, , +14

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible

Alexander Grabner, Karla Schramm, Neerupma Silswal et al. · Scientific Reports · 2017 · 137 citations · Full text

, , +14

Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease

Christopher Yanucil, Dominik Kentrup, Isaac Campos et al. · Kidney International · 2022 · 53 citations · Full text

, , +16

Cardioprotective Effects of Paricalcitol Alone and in Combination With FGF23 Receptor Inhibition in Chronic Renal Failure: Experimental and Clinical Studies

Brian Czaya, Wacharee Seeherunvong, Saurav Singh et al. · American Journal of Hypertension · 2018 · 28 citations · Full text

, , +16

FGF21-FGFR4 signaling in cardiac myocytes promotes concentric cardiac hypertrophy in mouse models of diabetes

Christopher Yanucil, Dominik Kentrup, Xueyi Li et al. · Scientific Reports · 2022 · 22 citations · Full text

, , +17

1–5 of 7